CD4 and neoplasm: In addition to direct antitumor activity, CD4+ CAR T cells may induce IFNγ-dependent remote cytolytic tumor cell death and promote host immune cell activation55,56, further complementing phagocytosis-potentiating therapeutic approaches like the one presented here (Fig. 9b).